National Research Corporation
NRC
$10.54
$0.010.10%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 143.06M | 144.15M | 146.28M | 147.42M | 148.58M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 143.06M | 144.15M | 146.28M | 147.42M | 148.58M |
Cost of Revenue | 56.93M | 56.38M | 55.70M | 55.59M | 56.02M |
Gross Profit | 86.13M | 87.78M | 90.58M | 91.83M | 92.57M |
SG&A Expenses | 44.89M | 44.53M | 45.32M | 46.06M | 46.59M |
Depreciation & Amortization | 6.02M | 5.94M | 5.95M | 5.95M | 5.90M |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 107.84M | 106.84M | 106.97M | 107.61M | 108.51M |
Operating Income | 35.22M | 37.32M | 39.32M | 39.82M | 40.07M |
Income Before Tax | 32.69M | 35.28M | 38.03M | 39.15M | 39.96M |
Income Tax Expenses | 7.91M | 8.20M | 8.76M | 8.78M | 8.99M |
Earnings from Continuing Operations | 24.78 | 27.08 | 29.27 | 30.37 | 30.97 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 24.78M | 27.08M | 29.27M | 30.37M | 30.97M |
EBIT | 35.22M | 37.32M | 39.32M | 39.82M | 40.07M |
EBITDA | 41.24M | 43.25M | 45.26M | 45.77M | 45.97M |
EPS Basic | 1.05 | 1.13 | 1.21 | 1.25 | 1.26 |
Normalized Basic EPS | 0.86 | 0.92 | 0.98 | 1.00 | 1.02 |
EPS Diluted | 1.05 | 1.13 | 1.21 | 1.24 | 1.25 |
Normalized Diluted EPS | 0.86 | 0.92 | 0.98 | 1.00 | 1.01 |
Average Basic Shares Outstanding | 94.81M | 95.90M | 96.74M | 97.44M | 98.16M |
Average Diluted Shares Outstanding | 94.99M | 96.17M | 97.12M | 97.92M | 98.70M |
Dividend Per Share | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 |
Payout Ratio | 46.22% | 42.77% | 123.79% | 119.59% | 117.42% |